Company: WCT
Filing Date: 2025-12-05
Form Type: 424B3
Source: 0001213900-25-118563
Chunk: 35

Company: Wellchange Holdings Co Ltd
Filing Date: 2025-12-05
Form: 424B3
Chunk 35
---
 and sell a total of 100,000,000 Class A Ordinary
Shares at the price of $0.04 per Class A Ordinary Share for gross proceeds of $4,000,000. The Offering was closed on September 19, 2025.

As of the date of this prospectus, the Company
has 145,265,000 Class A Ordinary Shares (including 100,000,000 Resale Shares) and 8,000,000 Class B Ordinary Shares issued and outstanding.

<div align='center'>12

Impact of COVID-19</div>

Since late December 2019, the outbreak of
COVID-19 has spread rapidly throughout China and later to the rest of the world. On January 30, 2020, the International Health Regulations
Emergency Committee of the World Health Organization declared the outbreak a “Public Health Emergency of International Concern”
(“PHEIC”), and later on March 11, 2020, a global pandemic. The COVID-19 outbreak has led governments across the globe
to impose a series of measures intended to contain its spread, including border closures, travel bans, quarantine measures, social distancing,
and restrictions on business operations and large gatherings. From 2020 to the middle of 2021, COVID-19 vaccination programs were greatly
promoted around the globe. However, several types of COVID-19 variants emerged in different parts of the world.

Our business may be adversely affected if
concerns relating to COVID-19 continue to restrict travel or result in the Company’s personnel, vendors, and services
providers being unavailable to pursue their business objectives free of COVID-19-related restrictions. The extent to which COVID-19
impacts our business in the future will depend on future developments, which are highly uncertain and cannot be predicted, including
new information that may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among
others. If the disruptions posed by COVID-19 or other matters of global concerns continue for an extended period of time, our
ability to pursue our business objectives may be materially adversely affected. In addition, our ability to raise equity and debt
financing, which may be adversely impacted by COVID-19 and other events, including as a result of increased market volatility,
decreased market liquidity, and third-party financing became unavailable on terms acceptable to us or at all.

By mid-2023, the global situation had stabilized
to some degree, with most countries having